1Berman R M,Fava M,Thase M E. Aripiprazole augmentation in major depressive disorder:a double-blind,placebo-controlled study in patients with inadequate response to antidepressants[J].{H}CNS SPECTRUMS,2009,(04):197-206.
2Trivedi M H,Thase M E,Fava M. Adjunctive aripiprazole in major depressive disorder:analysis of efficacy and safety in patients with anxious and atypical features[J].{H}Journal of Clinical Psychiatry,2008,(12):1928-1936.
3Weisler R H,Khan A,Trivedi M H. Analysis of suicidality in pooled data from 2 double-blind,placebo-controlled aripiprazole adjunctive therapy trials in major depressive disorder[J].{H}Journal of Clinical Psychiatry,2011,(04):548-555.
4Boulton D W,Balch A H,Royzman K. The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy:studies in healthy subjects and in patients with major depressive disorder[J].{H}Journal OF PSYCHOPHARMACOLOGY,2010,(04):537-546.
5Voronin K,Randall P,Myrick H. Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm-possible influence of self-control[J].{H}Alcohol Clinical Experimental Reseach,2008,(11):1954-1961.
6Myrick H,Li X,Randall P K. The effect of aripiprazole on cue-induced brain activation and drinking parameters in alcoholics[J].{H}Journal of Clinical Psychopharmacology,2010,(04):365-372.
7Martinotti G,Di Nicola M,Di Giannantonio M. Aripiprazole in the treatment of patients with alcohol dependence:a double-blind,comparison trial vs.naltrexone[J].{H}Journal OF PSYCHOPHARMACOLOGY,2009,(02):123-129.
8Liu Y,Bao Y P,Sun H Q. Long-term treatment with aripiprazole on the waking and postprandial urges to smoke in Chinese heavy smokers[J].{H}Journal of Clinical Psychopharmacology,2010,(04):373-380.
9Newton T F,Reid M S,De La Garza R. Evaluation of subjective effects of aripiprazole and methamphetamine in methamphetamine-dependent volunteers[J].{H}INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY,2008,(08):1037-1045.
10Young A H,Oren D A,Lowy A. Aripiprazole monotherapy in acute mania:12-week randomised placebo-and haloperidol-controlled study[J].{H}British Journal of Phychiatry,2009,(01):40-48.
